The Impact of Different Feeding Strategies During Packed Red Cell Transfusion on Intestinal Oxygenation
NCT ID: NCT02733718
Last Updated: 2016-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2015-11-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Manual and Mechanical Chest Compression During In-hospital Witnessed Cardiac Arrests Using Cerebral Oximetry
NCT03238287
Cerebral Circulation in Critically Ill Children
NCT03731104
Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery
NCT01866657
Validation of Near Infrared Spectroscopy (NIRS) During Heart-Lung Bypass in Children
NCT00745394
Optical Monitoring of Placental Oxygenation and Metabolism
NCT06886685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
"Restricted Transfusion Guidelines" will be used for the decision of transfusion in premature infants. Patients will be divided into three different groups, according to their feeding regimen during transfusion.
Group 1: No enteral feeding before (two hours), during (3 hours) and after (two hours) red blood cell transfusion.
Group 2: Enteral feeding is reduced by %50 before, during and after the red blood cell transfusion.
Group 3: The same feeding volume will be continued without decreasing or stopping.
Groups will be determined with randomization. It was targeted to be at least twenty infants in each group. In all patients, mesenteric oxygenation will be compared before-during and after blood transfusion. Mesenteric oxygenation will be measured with Near Infrared Spectroscopy (NIRS), that is a non-invasive NIRS conducted technology. Cerebral oxygenation and peripheral oxygen saturations will be measured at the same timeline.
The investigators primary aim is to show the best method of feeding during transfusion that causes less feeding intolerance and NEC. The secondary outcomes will be the risk factors associated with feeding intolerance and NEC during PRBC transfusion, in premature babies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: no enteral feeding
intervention: NIRS (near-infrared spectroscopy)
NIRS (near-infrared spectroscopy)
mesenteric oxygenisation measurement
Group 2: Feeding is reduced by %50
intervention: NIRS (near-infrared spectroscopy)
NIRS (near-infrared spectroscopy)
mesenteric oxygenisation measurement
Group 3: Feeding will be continued
intervention: NIRS (near-infrared spectroscopy)
NIRS (near-infrared spectroscopy)
mesenteric oxygenisation measurement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NIRS (near-infrared spectroscopy)
mesenteric oxygenisation measurement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Need for PRBC transfusion
* Feeding at least 30ml/kg/day at the time of transfusion
Exclusion Criteria
* Infants receiving continuous feeds or less than 30ml/kg/day
* Major congenital or chromosomal abnormalities or infants unlikely to survive
* Intraventricular hemorrhage \>Grade 3
* Hemodynamically significant patent ductus arteriosus
* Infants requiring vasopressor support
* Skin disruption precluding application of sensors
4 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hülya Selva Bilgen, MD
Role: STUDY_DIRECTOR
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marmara University School of Medicine
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Marin T. Mesenteric perfusion pattern changes as the result of packed red blood cell transfusions in preterm infants. (Doctoral Dissertation). 2012. Retrieved from Emory Electronic Theses and Dissertations Repository. UMI number 3522333. [cited 2013 Feb 20]
Marin T, Moore J, Kosmetatos N, Roback JD, Weiss P, Higgins M, McCauley L, Strickland OL, Josephson CD. Red blood cell transfusion-related necrotizing enterocolitis in very-low-birthweight infants: a near-infrared spectroscopy investigation. Transfusion. 2013 Nov;53(11):2650-8. doi: 10.1111/trf.12158. Epub 2013 Mar 11.
Bailey SM, Hendricks-Munoz KD, Mally P. Splanchnic-cerebral oxygenation ratio as a marker of preterm infant blood transfusion needs. Transfusion. 2012 Feb;52(2):252-60. doi: 10.1111/j.1537-2995.2011.03263.x. Epub 2011 Jul 25.
Stritzke AI, Smyth J, Synnes A, Lee SK, Shah PS. Transfusion-associated necrotising enterocolitis in neonates. Arch Dis Child Fetal Neonatal Ed. 2013 Jan;98(1):F10-4. doi: 10.1136/fetalneonatal-2011-301282. Epub 2012 Mar 23.
Christensen RD, Lambert DK, Henry E, Wiedmeier SE, Snow GL, Baer VL, Gerday E, Ilstrup S, Pysher TJ. Is "transfusion-associated necrotizing enterocolitis" an authentic pathogenic entity? Transfusion. 2010 May;50(5):1106-12. doi: 10.1111/j.1537-2995.2009.02542.x. Epub 2009 Dec 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MR-01022016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.